Federated Hermes’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Federated Hermes’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,677	Closed	-$4.84K	–	2257
2023 Q2	$4.84K	Buy	+2,677	New	+$4.89K	﹤0.01%	1905

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Federated Hermes's PRDS Position: Q3 2023 in Review

Federated Hermes sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 2,677 shares — an estimated $4.84K sold.

Federated Hermes first reported a position in PRDS in Q2 2023 and held it in 1 quarter. The position peaked at $4.84K in Q2 2023. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

Federated Hermes reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Federated Hermes sold 2,677 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $4.84K.
Federated Hermes first reported a position in Pardes Biosciences, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Federated Hermes's Pardes Biosciences, Inc. Common Stock position peaked at $4.84K in Q2 2023.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on Federated Hermes's 13F filing for Q3 2023, filed 13 Nov 2023.